1 |
S. Dey Sarkar, B. Farrugia, T. Dargaville, S. Dhara, Chitosan-collagen scaffolds with nano/micro fiber architecture for skin tissue engineering application, J. Biomedical Materials Research, Part A, 3482-3492, 2013 |
2 |
P. Datta, P. Ghosh, K. Ghosh, P. Maiti, S. K. Samanta, S. K. Ghosh, P. K. Das Mohapatra, J. Chatterjee, S Dhara, In Vitro ALP and Osteocalcin Gene Expression Analysisand In Vivo Biocompatibility of N-Methylene PhosphonicChitosan Nanofibers for Bone Regeneration, Journal of Biomedical Nanotechnology, 9, 1-10, 2013 |
3 |
P.C., Quan, A., Al-Omran, M., Lovren, F., Pan, Y., Brezden-Masley, C., Ingram, A.J., Stanford, W.L., Teoh, H., Verma, S., BRCA1 is a Novel Target to Improve Endothelial Dysfunction and Retard Atherosclerosis, Journal of Thoracic and Cardiovascular Surgery, 146, 2013 |
4 |
Quan, A., Lovren, F, Pan, Y., Wagg, C. S., Teoh, H., Lopaschuk, G. D., Verma, S., Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1, Journal of Thoracic and Cardiovascular Surgery, 2013 |
5 |
Mukherjee B., Mukhopadhyay R. , Bannerjee B. , Chowdhury S. , Naskar K. , Allam U. , Chakravortty D. , Sundar S. , Dujardin J. , Roy S., Antimony resistant Leishmania donovani upregulates IL-10 to overexpress host multi drug resistant protein1, Proc Natl Acad Sci U S A, 110, 575-582, 2013 |
6 |
Sen K., Mandal M., Second generation liposomal cancer therapeutics: transition from laboratory to clinic, Int J Pharm, 28-43, 2013 |
7 |
Rajput S., Kumar B. N., Sarkar S. , Fisher P. B., Mandal M., Targeted apoptotic effects of thymoquinone and tamoxifen on XIAP mediated Akt regulation in breast cancer, Plos One, 2013 |
8 |
SINGH, A. K., CHATTOPADHYAY, R., CHAKRAVARTY, B. & CHAUDHURY, K., Markers of oxidative stress in follicular fluid of women with endometriosis and tubal infertility undergoing IVF, Reprod. Toxicol, 116-124, 2013 |